WO2006108373A8 - KOMPLEXE AUS VITAMIN D-VERBINDUNGEN ODER DEREN ANALOGA MIT EINEM 5Z,7E,10(19)-TRIEN-SYSTEM UND METHYLIERTEN DERIVATEN DES ß-CYCLODEXTRINS - Google Patents

KOMPLEXE AUS VITAMIN D-VERBINDUNGEN ODER DEREN ANALOGA MIT EINEM 5Z,7E,10(19)-TRIEN-SYSTEM UND METHYLIERTEN DERIVATEN DES ß-CYCLODEXTRINS

Info

Publication number
WO2006108373A8
WO2006108373A8 PCT/DE2006/000343 DE2006000343W WO2006108373A8 WO 2006108373 A8 WO2006108373 A8 WO 2006108373A8 DE 2006000343 W DE2006000343 W DE 2006000343W WO 2006108373 A8 WO2006108373 A8 WO 2006108373A8
Authority
WO
WIPO (PCT)
Prior art keywords
cyclodextrin
analogues
vitamin
compounds
complexes consisting
Prior art date
Application number
PCT/DE2006/000343
Other languages
English (en)
French (fr)
Other versions
WO2006108373A1 (de
Inventor
Juergen Westermann
Gabriele Winter
Karsten Hoyer
Adrian Funke
Original Assignee
Schering Ag
Juergen Westermann
Gabriele Winter
Karsten Hoyer
Adrian Funke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag, Juergen Westermann, Gabriele Winter, Karsten Hoyer, Adrian Funke filed Critical Schering Ag
Publication of WO2006108373A1 publication Critical patent/WO2006108373A1/de
Publication of WO2006108373A8 publication Critical patent/WO2006108373A8/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Medical Informatics (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Die Erfindung betrifft Komplexe aus Vitamin D-Verbindungen oder deren Analoga mit einem 5Z,7E,10(19)-Trien-System und methylierten Derivaten des ß-Cyclodextrins, insbesondere einen Komplex aus (Thiazol-2-yl)-26,27-dinor-9,10-secocholesta-5,7, 10(19)-triene-1 ,3,25-triol und Heptakis-(2,6-di-O-methyl)- ß-Cyclodextrin (DIMEB).
PCT/DE2006/000343 2005-04-13 2006-02-22 KOMPLEXE AUS VITAMIN D-VERBINDUNGEN ODER DEREN ANALOGA MIT EINEM 5Z,7E,10(19)-TRIEN-SYSTEM UND METHYLIERTEN DERIVATEN DES ß-CYCLODEXTRINS WO2006108373A1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE102005017775.1 2005-04-13
DE102005017775A DE102005017775A1 (de) 2005-04-13 2005-04-13 Komplexe aus Vitamin D-Verbindungen oder deren Analoga mit einem 5Z,7E,10(19)-Trien-System und methlierten Derivaten des ß-Cyclodextrins
US67336005P 2005-04-21 2005-04-21
US60/673,360 2005-04-21

Publications (2)

Publication Number Publication Date
WO2006108373A1 WO2006108373A1 (de) 2006-10-19
WO2006108373A8 true WO2006108373A8 (de) 2007-03-15

Family

ID=37055487

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE2006/000343 WO2006108373A1 (de) 2005-04-13 2006-02-22 KOMPLEXE AUS VITAMIN D-VERBINDUNGEN ODER DEREN ANALOGA MIT EINEM 5Z,7E,10(19)-TRIEN-SYSTEM UND METHYLIERTEN DERIVATEN DES ß-CYCLODEXTRINS

Country Status (3)

Country Link
US (1) US20070093448A1 (de)
DE (1) DE102005017775A1 (de)
WO (1) WO2006108373A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070119928A1 (en) * 2005-11-17 2007-05-31 Jung Edward K Generating a nutraceutical request from an inventory
US20070112592A1 (en) * 2005-11-17 2007-05-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Payments in providing assistance related to health
US10042980B2 (en) * 2005-11-17 2018-08-07 Gearbox Llc Providing assistance related to health
US20070112796A1 (en) * 2005-11-17 2007-05-17 Jung Edward K Research in providing assistance related to health
US20070124175A1 (en) * 2005-11-30 2007-05-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware. Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US20080082272A1 (en) * 2005-11-30 2008-04-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems and methods related to nutraceuticals
US20070124219A1 (en) * 2005-11-30 2007-05-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized nutraceutical selection and packaging
US20070136092A1 (en) * 2005-11-30 2007-06-14 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging
US20070124176A1 (en) * 2005-11-30 2007-05-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US20080193919A1 (en) * 2005-11-30 2008-08-14 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Systems and methods for receiving pathogen related information and responding
US10296720B2 (en) * 2005-11-30 2019-05-21 Gearbox Llc Computational systems and methods related to nutraceuticals
US20070299695A1 (en) * 2006-06-23 2007-12-27 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Customized visual marking for medication labeling
KR100822133B1 (ko) * 2006-11-06 2008-04-15 한미약품 주식회사 비타민 ｄ 또는 이의 유도체의 고체분산체 및비스포스포네이트를 포함하는, 골다공증 예방 또는 치료용복합제제
EP2106786A1 (de) * 2008-04-04 2009-10-07 Roewer, Norbert, Univ.-Prof. Dr. med. Pharmazeutische Zubereitung mit permethyliertem Cyclodextrin
FR2953139B1 (fr) * 2009-11-27 2012-04-13 Servier Lab Composition pharmaceutique comprenant un sel de strontium, de la vitamine d et une cyclodextrine
US9925274B2 (en) 2012-11-15 2018-03-27 Sapiotec Gmbh Delphinidin complex as an antiphlogistic or immunosuppressive active ingredient
CA2893883A1 (en) 2012-12-11 2014-06-19 Sapiotec Gmbh Delphinidin for combating melanoma cells
CN107156456A (zh) * 2017-05-15 2017-09-15 南京群汇化工有限公司 25‑羟基维生素d3包合物及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU181703B (en) * 1980-05-09 1983-11-28 Chinoin Gyogyszer Es Vegyeszet Process for producing aqueus solutuins of water insoluble or hardly soluble vitamines, steroides, localanesthetics, prostanoides and non-steroid and antiphlogistic agents
DE19549243A1 (de) * 1995-12-21 1997-06-26 Schering Ag Pharmazeutische Präparate enthaltend Clathrate von Cyclodextrinen und nichtnatürliche Vitamin D-Analoga
DE19935771A1 (de) * 1999-07-23 2001-02-01 Schering Ag Neue Vitamin D-Derivate mit cyclischen Substrukturen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
FR2835434B1 (fr) * 2002-02-01 2006-03-03 Lvmh Rech Utilisation cosmetique ou dermatologique de la vitamine a ou de ses esters, en association avec une beta-cyclodextrine partiellement methylee

Also Published As

Publication number Publication date
DE102005017775A1 (de) 2006-10-19
US20070093448A1 (en) 2007-04-26
WO2006108373A1 (de) 2006-10-19

Similar Documents

Publication Publication Date Title
WO2006108373A8 (de) KOMPLEXE AUS VITAMIN D-VERBINDUNGEN ODER DEREN ANALOGA MIT EINEM 5Z,7E,10(19)-TRIEN-SYSTEM UND METHYLIERTEN DERIVATEN DES ß-CYCLODEXTRINS
WO2007005739A3 (en) Computer graphics shader systems and methods
WO2007086855A3 (en) Medical devices including nanocomposites
WO2007122374A3 (en) Colonic drug delivery formulation
WO2007050656A3 (en) Dietary fiber formulation and method of administration
WO2004023527A3 (en) Nanostructure and nanocomposite based compositions and photovoltaic devices
WO2007025767A3 (de) Nanopartikulärer einschluss- und ladungskomplex für pharmazeutische formulierungen
EP4295908A3 (de) Neuroaktive steroidformulierungen mit einem komplex aus allopregnanolon und sulfobutylether-beta-cyclodextrin
WO2006128646A3 (en) Elastomeric structures
JP2009537572A5 (de)
WO2008000670A3 (en) Pressure bulkhead for an aerospace fuselage
TW200626650A (en) Rubber formulation and methods for manufacturing same
WO2009086343A3 (en) Microorganism-capturing compositions and methods
LUC00065I1 (de)
WO2007025236A3 (en) Alignment instrument for dynamic spinal stabilization systems
HK1061520A1 (en) Disinfecting and solubilizing steroid compositions
WO2010138837A3 (en) Nanodiamond particle complexes
ATE411238T1 (de) Verpackungseinheit, insbesondere für wischblätter
MX2008016039A (es) Preparacion de glucano.
WO2004103348A3 (en) Solid particles comprising an anticonvulsant or an immunosuppressive coated with one or more surface modifiers
ZA200709921B (en) Biologically active formulation based on cyclodextrin supramolecular complexes
USD549166S1 (en) Tire for a car
WO2009058387A3 (en) Oligomer-nitroimidazole anti-infective conjugates
WO2000037109A3 (en) Clathrates of dehydroepiandrosterone and corresponding pharmaceutical compositions
EP1469886B8 (de) Lyophilisierte pharmazeutische zusammensetzung von propofol

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: RU

WWW Wipo information: withdrawn in national office

Country of ref document: RU

122 Ep: pct application non-entry in european phase

Ref document number: 06706012

Country of ref document: EP

Kind code of ref document: A1

WWW Wipo information: withdrawn in national office

Ref document number: 6706012

Country of ref document: EP